| SC 13G/A | 2024-02-14 | BAKER BROS. ADVISORS LP | HERON THERAPEUTICS, INC. /DE/ | 7,881,933 | 5.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | HERON THERAPEUTICS, INC. /DE/ | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | GREAT POINT PARTNERS LLC | HERON THERAPEUTICS, INC. /DE/ | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | HERON THERAPEUTICS, INC. /DE/ | 8,338,912 | 5.6% | EDGAR |
| SC 13G/A | 2024-02-06 | FRANKLIN RESOURCES INC | HERON THERAPEUTICS, INC. /DE/ | 6,404,795 | 4.3% | EDGAR |
| SC 13G/A | 2023-12-07 | JPMORGAN CHASE & CO | HERON THERAPEUTICS, INC. /DE/ | 84,549 | 0.0% | EDGAR |
| SC 13G/A | 2023-12-06 | BlackRock Inc. | HERON THERAPEUTICS, INC. /DE/ | 7,037,314 | 4.7% | EDGAR |
| SC 13D/A | 2023-07-25 | Rubric Capital Management LP | HERON THERAPEUTICS, INC. /DE/ | 26,713,503 | 19.0% | EDGAR |
| SC 13G | 2023-04-13 | GREAT POINT PARTNERS LLC | HERON THERAPEUTICS, INC. /DE/ | 6,360,161 | 5.4% | EDGAR |
| SC 13D/A | 2023-02-22 | Rubric Capital Management LP | HERON THERAPEUTICS, INC. /DE/ | 11,750,000 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-15 | ArrowMark Colorado Holdings LLC | HERON THERAPEUTICS, INC. /DE/ | 3,560,848 | 3.0% | EDGAR |
| SC 13G/A | 2023-02-14 | TANG CAPITAL PARTNERS LP | HERON THERAPEUTICS, INC. /DE/ | 3,755,934 | 3.2% | EDGAR |
| SC 13G/A | 2023-02-13 | UBS OCONNOR LLC | HERON THERAPEUTICS, INC. /DE/ | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | HERON THERAPEUTICS, INC. /DE/ | 7,806,285 | 6.6% | EDGAR |
| SC 13D | 2023-02-06 | Rubric Capital Management LP | HERON THERAPEUTICS, INC. /DE/ | 11,750,000 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-03 | BlackRock Inc. | HERON THERAPEUTICS, INC. /DE/ | 9,650,709 | 8.1% | EDGAR |
| SC 13G/A | 2023-01-31 | FRANKLIN RESOURCES INC | HERON THERAPEUTICS, INC. /DE/ | 11,867,780 | 10.0% | EDGAR |
| SC 13G/A | 2023-01-23 | JPMORGAN CHASE & CO | HERON THERAPEUTICS, INC. /DE/ | 6,753,629 | 5.6% | EDGAR |
| SC 13G/A | 2023-01-10 | STATE STREET CORP | HERON THERAPEUTICS, INC. /DE/ | - | 2.2% | EDGAR |
| SC 13G | 2022-08-19 | Deep Track Capital, LP | HERON THERAPEUTICS, INC. /DE/ | 12,232,267 | 10.0% | EDGAR |